Primary Biliary Cholangitis: Pathophysiology
- PMID: 37945164
- DOI: 10.1016/j.cld.2023.06.006
Primary Biliary Cholangitis: Pathophysiology
Abstract
Primary biliary cholangitis (PBC) is the most common of the autoimmune liver diseases, in which there is chronic small bile duct inflammation. The pathophysiology of PBC is multifactorial, involving immune dysregulation and damage to biliary epithelial cells, with influences from genetic factors, epigenetics, the gut-liver axis, and environmental exposures.
Keywords: Autoimmune; Biliary epithelial cell; Epigenetics; GWAS.
Copyright © 2023 Elsevier Inc. All rights reserved.
Similar articles
-
[Immune pathogenesis of primary biliary cholangitis].Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):500-504. doi: 10.3760/cma.j.cn501113-20210430-00213. Zhonghua Gan Zang Bing Za Zhi. 2021. PMID: 34225423 Chinese.
-
Immunological abnormalities in patients with primary biliary cholangitis.Clin Sci (Lond). 2019 Mar 19;133(6):741-760. doi: 10.1042/CS20181123. Print 2019 Mar 29. Clin Sci (Lond). 2019. PMID: 30890652 Review.
-
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.Pathologica. 2021 Jun;113(3):170-184. doi: 10.32074/1591-951X-245. Pathologica. 2021. PMID: 34294935 Free PMC article. Review.
-
The Genetics of Primary Biliary Cholangitis: A GWAS and Post-GWAS Update.Genes (Basel). 2023 Feb 3;14(2):405. doi: 10.3390/genes14020405. Genes (Basel). 2023. PMID: 36833332 Free PMC article. Review.
-
Epigenetics of Primary Biliary Cholangitis.Adv Exp Med Biol. 2020;1253:259-283. doi: 10.1007/978-981-15-3449-2_10. Adv Exp Med Biol. 2020. PMID: 32445099 Review.
Cited by
-
Hepatic bile acid accretion correlates with cholestatic liver injury and therapeutic response in Cyp2c70 knockout mice with a humanized bile acid composition.Am J Physiol Gastrointest Liver Physiol. 2024 Dec 1;327(6):G789-G809. doi: 10.1152/ajpgi.00129.2024. Epub 2024 Oct 1. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 39350733
-
Alcohol Consumption and Autoimmune Diseases.Int J Mol Sci. 2025 Jan 20;26(2):845. doi: 10.3390/ijms26020845. Int J Mol Sci. 2025. PMID: 39859557 Free PMC article. Review.
-
Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment.Clin Pharmacol Ther. 2025 Jan;117(1):240-249. doi: 10.1002/cpt.3450. Epub 2024 Oct 2. Clin Pharmacol Ther. 2025. PMID: 39355940 Free PMC article.
-
Seladelpar: First Approval.Drugs. 2024 Nov;84(11):1487-1495. doi: 10.1007/s40265-024-02114-4. Epub 2024 Nov 22. Drugs. 2024. PMID: 39572508 Review.
-
Molecular Hydrogen Capsule Therapy for Primary Biliary Cholangitis With Elevated IgG4: A Case Report on Immune Marker Normalization.In Vivo. 2025 May-Jun;39(3):1669-1675. doi: 10.21873/invivo.13968. In Vivo. 2025. PMID: 40295001 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical